SCHEMBL65638

SCHEMBL65638

CCCCCCCCC1=CC(=O)NC1=O

nearest known ligand 0.50

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.50
BACE1 P56817 1/20 0.50
ALOX5 P09917 10/20 0.44
PTGS2 P35354 5/20 0.44
PTPN1 P18031 1/20 0.44
GLS2 Q9UI32 1/20 0.44
GPR84 Q9NQS5 8/20 0.40
MPEG1 Q2M385 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1578738 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1
SCHEMBL1578445 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1
SCHEMBL12501883 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1
SCHEMBL1578823 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1
SCHEMBL465095 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1
SCHEMBL1578876 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1
SCHEMBL14720387 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1
SCHEMBL36399 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1
SCHEMBL1578870 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1
SCHEMBL30091820 1.00 ACHE (0.50) ACHEBACE1ALOX5PTGS2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028317-A1 EFFICIENT PROCEDURE FOR THE SYNTHESIS OF HYDRAZONE-LINKED TETRAHEDRAL NANOCAGES UNIV VERMONT (US) 2026-01-29 US claimed
WO-2024015528-A1 EFFICIENT PROCEDURE FOR THE SYNTHESIS OF HYDRAZONE-LINKED TETRAHEDRAL NANOCAGES UNIVERSITY OF VERMONT (US) 2024-01-18 WO claimed
US-20230303472-A1 MOLECULAR TETRAHEDRON NANOCAGE, ITS PREPARATION, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2023-09-28 US claimed
CN-116023592-A Crude oil fluidity improver and preparation method thereof 西安石油大学 2023-04-28 CN claimed
WO-2022228846-A1 METHOD FOR PRODUCING A TERMINAL-FUNCTIONAL POLYMER BASF SE (DE) 2022-11-03 WO claimed
EP-3636634-B1 METHOD FOR PURIFYING N-SUBSTITUTED MALEIMIDE LG CHEMICAL LTD (KR) 2022-06-22 EP claimed
WO-2022117389-A1 METHOD FOR PRODUCING A TERMINAL-FUNCTIONAL POLYMER BASF SE (DE) 2022-06-09 WO claimed
US-11345661-B2 Method for purifying N-substituted maleimide LG CHEM, LTD. (KR) 2022-05-31 US claimed
CN-109071432-B Synthesis method of N-substituted maleimide by using solid acid catalyst 株式会社LG化学 2022-04-12 CN claimed
US-20210355083-A1 METHOD FOR PURIFYING N-SUBSTITUTED MALEIMIDE LG CHEM, LTD. (KR) 2021-11-18 US claimed
US-20190152910-A1 SYNTHESIS METHOD OF N-SUBSTITUTED MALEIMIDE USING SOLID ACID CATALYSTS LG CHEM, LTD. (KR) 2019-05-23 US claimed
EP-3421451-A1 METHOD FOR PRODUCING N-SUBSTITUTED MALEIMIDE USING SOLID ACID CATALYST LG Chem, Ltd. (KR) 2019-01-02 EP claimed
CN-109096442-A A kind of method of primary reconstruction toughening modifying bimaleimide resin 中国航发北京航空材料研究院 2018-12-28 CN claimed
CN-109071432-A Synthesis method of N-substituted maleimide by using solid acid catalyst 株式会社LG化学 2018-12-21 CN claimed
JP-2011524942-A 2011-09-08 JP claimed
EP-2291412-A2 APPARATUS AND METHODS FOR CONTROLLED RADICAL POLYMERIZATION Henkel Corporation (US) 2011-03-09 EP claimed
WO-2009155303-A2 APPARATUS AND METHODS FOR CONTROLLED RADICAL POLYMERIZATION HENKEL CORPORATION (US) 2009-12-23 WO claimed
EP-0230597-B1 METHOD FOR INHIBITING POLYMERIZATION OF MALEIMIDES Nippon Shokubai Kagaku Kogyo Co., Ltd (JP) 1992-04-08 EP claimed
EP-0262796-A2 Resin compositons and their manufacturing method TORAY INDUSTRIES, INC. (JP) 1988-04-06 EP claimed
EP-0230597-A2 Method for inhibiting polymerization of maleimides Nippon Shokubai Kagaku Kogyo Co., Ltd (JP) 1987-08-05 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303472-A1 MOLECULAR TETRAHEDRON NANOCAGE, ITS PREPARATION, AND USES THEREOF TUBB2B, TUBB2A, TUBA1A ACHE 2181/4885BACE1 4426/4885ALOX5 4299/4885
US-20260028317-A1 EFFICIENT PROCEDURE FOR THE SYNTHESIS OF HYDRAZONE-LINKED TETRAHEDRAL NANOCAGES FTH1, AOC2, CCRL2 ACHE 4178/4885BACE1 4577/4885ALOX5 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.